Holen Sie sich die Stockscreener-App
78.05
0.91%
-0.79
Schlusskurs vom Vortag:
$78.84
Offen:
$78.99
24-Stunden-Volumen:
468.63K
Relative Volume:
0.51
Marktkapitalisierung:
$5.18B
Einnahmen:
$1.50B
Nettoeinkommen (Verlust:
$427.61M
KGV:
12.99
EPS:
6.01
Netto-Cashflow:
$423.98M
1W Leistung:
+3.17%
1M Leistung:
+18.49%
6M Leistung:
+45.16%
1J Leistung:
-20.42%
1-Tages-Spanne:
$77.51
$80.00
1-Wochen-Bereich:
$72.94
$80.91
52-Wochen-Spanne:
$47.25
$111.29
Lantheus Holdings Inc Stock (LNTH) Company Profile
Firmenname
Lantheus Holdings Inc
Sektor
Telefon
978 671-8001
Adresse
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
78.16 | 5.23B | 1.50B | 427.61M | 423.98M | 6.01 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.21 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
126.73 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.47 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.51 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
488.06 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-12 | Hochstufung | Truist | Hold → Buy |
| 2025-10-08 | Herabstufung | Goldman | Buy → Neutral |
| 2025-08-12 | Herabstufung | Truist | Buy → Hold |
| 2024-12-18 | Eingeleitet | Goldman | Buy |
| 2024-09-03 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-07-10 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-12-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Eingeleitet | TD Cowen | Outperform |
| 2023-09-29 | Eingeleitet | William Blair | Outperform |
| 2023-03-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-11-30 | Eingeleitet | SVB Leerink | Outperform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-05-09 | Eingeleitet | B. Riley Securities | Buy |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2021-02-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-29 | Fortgesetzt | Jefferies | Buy |
| 2019-08-16 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-09-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2016-02-24 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-12-11 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Eingeleitet | Credit Suisse | Outperform |
| 2015-07-20 | Eingeleitet | Jefferies | Buy |
| 2015-07-20 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-07-20 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-20 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten
William Blair Investment Management LLC Has $29.48 Million Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat
Intech Investment Management LLC Sells 33,704 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus receives FDA tentative approval for generic cancer drug By Investing.com - Investing.com Canada
Lantheus Holdings (LNTH): Analyst Raises Price Target to $89 | L - GuruFocus
Lantheus (LNTH) Secures FDA Tentative Nod for New Cancer Treatme - GuruFocus
Lantheus Says US FDA Tentatively Approves PNT2003 - marketscreener.com
FDA tentatively backs new tumor therapy similar to LUTATHERA - Stock Titan
Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Innovator with a 21% Upside Potential - DirectorsTalk Interviews
Assessing Lantheus Holdings (LNTH) Valuation After Recent Share Price Rebound And PYLARIFY Outlook - Yahoo Finance UK
Lantheus Holdings, Inc. $LNTH Shares Sold by Artisan Partners Limited Partnership - MarketBeat
Lantheus Holdings (LNTH) Net Margin Decline Tests Bullish Earnings Growth Narrative - Sahm
TD Asset Management Inc Increases Stock Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
Dana Investment Advisors Inc. Sells 13,875 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
Seaport Global Upgrades LNTH to Neutral Feb 27, 2026 Lantheus Holdings, Inc - Meyka
Lantheus (NASDAQ:LNTH) Price Target Raised to $85.00 at Mizuho - MarketBeat
LNTH: Mizuho Raises Price Target to $85, Maintains Outperform Ra - GuruFocus
Truist Securities Adjusts Lantheus Holdings PT to $89 From $82, Maintains Buy Rating - marketscreener.com
LNTH: 2025 Earnings Flash Report - Zacks Small Cap Research
Citizens Analyst Raises Lantheus Holdings (LNTH) Price Target to $85.00 | LNTH Stock News - GuruFocus
Lantheus (NASDAQ:LNTH) Given "Hold" Rating at JonesTrading - MarketBeat
Lantheus Holdings (LNTH) Downgraded to Hold by Jones Trading | L - GuruFocus
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q4 2025 Earnings Call Transcript - Insider Monkey
Vanguard Group Inc. Raises Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
Citizens raises Lantheus stock price target on strong Q4 results By Investing.com - Investing.com Canada
Decoding Lantheus Holdings Inc (LNTH): A Strategic SWOT Insight - GuruFocus
Lantheus (NASDAQ:LNTH) Releases Earnings Results - MarketBeat
William Blair Upgrades Lantheus Holdings (LNTH) to Outperform Feb 26, 2026 - Meyka
Lantheus Holdings (LNTH) Reports Revenue Growth and Strategic Sh - GuruFocus
Jones Trading downgrades Lantheus stock rating to hold on revenue outlook By Investing.com - Investing.com South Africa
Lantheus Earnings Call Maps Painful Reset Before 2027 - TipRanks
Jones Trading downgrades Lantheus stock rating to hold on revenue outlook - Investing.com
Lantheus Q4 Earnings Call Highlights - MarketBeat
Lantheus Holdings Inc (LNTH) Q4 2025 Earnings Call Highlights: N - GuruFocus
Lantheus (LNTH) Q4 2025 Earnings Call Transcript - AOL.com
Lantheus Holdings, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:LNTH) 2026-02-26 - Seeking Alpha
Lantheus (NASDAQ:LNTH) Stock Rating Upgraded by William Blair - MarketBeat
Lantheus (NASDAQ:LNTH) Exceeds Q4 CY2025 Expectations - Finviz
William Blair upgrades Lantheus stock rating on product pipeline - Investing.com
Lantheus (LNTH) Given an Upgrade Amid Promising Growth Prospects - GuruFocus
Lantheus Q4 2025 slides: earnings beat masks flagship product decline - Investing.com Australia
Lantheus Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Lantheus Holdings Inc earnings beat by $0.51, revenue topped estimates - Investing.com South Africa
Earnings call transcript: Lantheus Holdings Inc Q4 2025 beats forecasts but faces market dip - Investing.com
Lantheus Q4 2025 slides: earnings beat masks flagship product decline By Investing.com - Investing.com Canada
Lantheus’s 2026 Revenue Guidance Amid Expected Q4 Decline Might Change The Case For Investing In LNTH - simplywall.st
Lantheus Q4 Adjusted Earnings, Revenue Rise; Sets 2026 Guidance - marketscreener.com
Lantheus Holdings: Fourth Quarter Earnings Overview - Bitget
Lantheus (NASDAQ:LNTH) Releases FY 2026 Earnings Guidance - MarketBeat
Lantheus Holdings, Inc. Provides Earnings Guidance for the Year 2026 - marketscreener.com
Tranche Update on Lantheus Holdings, Inc.'s Equity Buyback Plan announced on August 6, 2025. - marketscreener.com
Lantheus (LNTH) Revises Revenue Forecast Below Market Expectatio - GuruFocus
Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):